pfizer

Bio & Pharma Samsung Biologics wins $897 mn in two deals with Pfizer

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...

Bio & Pharma Samsung Biologics, Pfizer sign $411.3 mn agreement for long-term CDMO

Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...

Korean chipmakers Samsung Chairman Lee to meet new premier in China

Samsung Electronics Co. Chairman Jay Y. Lee arrived in Beijing on March 23 to review the chipmaker’s business in China, which is gradually rec...

Bio & Pharma Samsung Biologics bags $183 million CMO order from Pfizer

Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...

Real estate Pfizer Korea HQ sale falls through on investors' tepid interest

South Korea’s GRE Partners Asset Management Co. a real estate investment firm, has recently suspended the selling process for Pfizer Pharmaceu...

COVID-19 SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

COVID vaccines Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine

South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...